source
- Merck launches voluntary licensing for investigational monthly HIV PrEP pill ahead of approvalMerck has signed voluntary licensing agreements to allow generic manufacturers to produce its investigational monthly HIV PrEP pill, alimatravir, before any regulatory submission. The agreements c…
- U.S. drug shortages stem from weak regulation, not China competition, says expertIn 2025 the United States faced 216 active drug shortages, limiting access to lifesaving medicines for patients. While the White House and national‑security officials have framed the problem as a…